SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-007304
Filing Date
2023-03-10
Accepted
2023-03-10 16:27:33
Documents
13
Period of Report
2023-03-07
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K cue-20230307.htm   iXBRL 8-K 69766
  Complete submission text file 0000950170-23-007304.txt   211560

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cue-20230307_pre.xml EX-101.PRE 13511
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cue-20230307_lab.xml EX-101.LAB 16077
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cue-20230307.xsd EX-101.SCH 2917
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cue-20230307_def.xml EX-101.DEF 13504
7 EXTRACTED XBRL INSTANCE DOCUMENT cue-20230307_htm.xml XML 4511
Mailing Address 40 GUEST STREET BOSTON MA 02135
Business Address 40 GUEST STREET BOSTON MA 02135 617-949-2680
Cue Biopharma, Inc. (Filer) CIK: 0001645460 (see all company filings)

IRS No.: 473324577 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38327 | Film No.: 23724054
SIC: 2834 Pharmaceutical Preparations